ALGN
Price
$126.19
Change
+$1.31 (+1.05%)
Updated
Sep 26 closing price
Capitalization
9.15B
31 days until earnings call
SUVPF
Price
$221.24
Change
-$5.51 (-2.43%)
Updated
Sep 5 closing price
Capitalization
14.2B
Interact to see
Advertisement

ALGN vs SUVPF

Header iconALGN vs SUVPF Comparison
Open Charts ALGN vs SUVPFBanner chart's image
Align Technology
Price$126.19
Change+$1.31 (+1.05%)
Volume$909.28K
Capitalization9.15B
Sartorius AG
Price$221.24
Change-$5.51 (-2.43%)
Volume$209
Capitalization14.2B
ALGN vs SUVPF Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUVPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. SUVPF commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Buy and SUVPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ALGN: $126.19 vs. SUVPF: $221.24)
Brand notoriety: ALGN: Notable vs. SUVPF: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALGN: 51% vs. SUVPF: 224%
Market capitalization -- ALGN: $9.15B vs. SUVPF: $14.2B
ALGN [@Pharmaceuticals: Other] is valued at $9.15B. SUVPF’s [@Pharmaceuticals: Other] market capitalization is $14.2B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.13B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileSUVPF’s FA Score has 0 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • SUVPF’s FA Score: 0 green, 5 red.
According to our system of comparison, ALGN is a better buy in the long-term than SUVPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 4 TA indicator(s) are bullish while SUVPF’s TA Score has 5 bullish TA indicator(s).

  • ALGN’s TA Score: 4 bullish, 3 bearish.
  • SUVPF’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, SUVPF is a better buy in the short-term than ALGN.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а -3.96% price change this week, while SUVPF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SUVPF($14.2B) has a higher market cap than ALGN($9.15B). SUVPF has higher P/E ratio than ALGN: SUVPF (125.59) vs ALGN (21.32). SUVPF YTD gains are higher at: 0.639 vs. ALGN (-39.480). SUVPF has higher annual earnings (EBITDA): 844M vs. ALGN (793M). ALGN (901M) and SUVPF (872M) have equal amount of cash in the bank . ALGN has less debt than SUVPF: ALGN (123M) vs SUVPF (4.66B). ALGN has higher revenues than SUVPF: ALGN (3.97B) vs SUVPF (3.47B).
ALGNSUVPFALGN / SUVPF
Capitalization9.15B14.2B64%
EBITDA793M844M94%
Gain YTD-39.4800.639-6,180%
P/E Ratio21.32125.5917%
Revenue3.97B3.47B114%
Total Cash901M872M103%
Total Debt123M4.66B3%
FUNDAMENTALS RATINGS
ALGN vs SUVPF: Fundamental Ratings
ALGN
SUVPF
OUTLOOK RATING
1..100
5550
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6687
PRICE GROWTH RATING
1..100
6580
P/E GROWTH RATING
1..100
9488
SEASONALITY SCORE
1..100
8565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGN's Valuation (73) in the Medical Specialties industry is in the same range as SUVPF (81) in the null industry. This means that ALGN’s stock grew similarly to SUVPF’s over the last 12 months.

ALGN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SUVPF (100) in the null industry. This means that ALGN’s stock grew similarly to SUVPF’s over the last 12 months.

ALGN's SMR Rating (66) in the Medical Specialties industry is in the same range as SUVPF (87) in the null industry. This means that ALGN’s stock grew similarly to SUVPF’s over the last 12 months.

ALGN's Price Growth Rating (65) in the Medical Specialties industry is in the same range as SUVPF (80) in the null industry. This means that ALGN’s stock grew similarly to SUVPF’s over the last 12 months.

SUVPF's P/E Growth Rating (88) in the null industry is in the same range as ALGN (94) in the Medical Specialties industry. This means that SUVPF’s stock grew similarly to ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNSUVPF
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
57%
Momentum
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
46%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
71%
Bullish Trend 3 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
40%
Advances
ODDS (%)
Bullish Trend 24 days ago
75%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
71%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUVPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TALK2.780.14
+5.30%
Talkspace
HNI46.101.26
+2.81%
HNI Corp
ALTO1.090.02
+1.87%
Alto Ingredients
RDY14.220.06
+0.42%
Dr. Reddy's Laboratories Ltd
NVVE0.23N/A
-0.61%
Nuvve Holding Corp

SUVPF and

Correlation & Price change

A.I.dvisor tells us that SUVPF and TLSI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SUVPF and TLSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUVPF
1D Price
Change %
SUVPF100%
N/A
TLSI - SUVPF
26%
Poorly correlated
-1.26%
ALGN - SUVPF
22%
Poorly correlated
+1.05%
GKOS - SUVPF
22%
Poorly correlated
-1.90%
SOAGY - SUVPF
21%
Poorly correlated
+0.63%
UEEC - SUVPF
20%
Poorly correlated
-8.39%
More